Bin Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bin Tang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Aopu Zhang
1 shared publicationBin Tang
State Key Laboratory of Electronic Thin Films and Integrated Devices, National Engineering Center of Electromagnetic Radiation Control Materials, University of Electronic Science and Technology of China, Chengdu 611731, China
1 shared publication- Hao Wang
Department of Breast, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610041, China
1 shared publication Hui Li
Department of Breast, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610041, China
1 shared publication- Jinyi Lang
School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
1 shared publication Junyang Chen
Chengdu University of Traditional Chinese Medicine, Chengdu, 610032, China
1 shared publication
Latest Publications
- Open Access
- 2 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (40)
Intratumoral therapeutic dust for chemo-photodynamic combination treatment
Implantable wireless ultrasound microdevices for intratumoral therapy are hindered by inadequate miniaturization for deep-seated sites and toxic lead-based piezoelectrics. Here, we report an injectable, lead-free, submillimeter therapeutic dust (TheraDust; 1.0 millimeters by 1.0 millimeters by 0.9 millimeters) for ultrasound-driven wireless chemo-photodynamic combined therapy. The core of the device is a lead-free tin-doped barium titanate piezoelectric ceramic that features a multiphase coexistence at physiological temperature and exhibits a high piezoelectric coefficient ( d 33 = 460 picocoulombs per newton). The TheraDust integrates with an ultrasound-responsive drug-loaded hydrogel for precise intratumoral injection. Under programmable ultrasound, it generates light for photodynamic therapy and triggers on-demand chemotherapeutic release for enhanced treatment. In animal models of breast cancer, the device achieved potent tumor suppression, reducing the final tumor volume to less than 3% after five treatment sessions (5 minutes each) and could be retrieved minimally invasively posttreatment. This platform can be adapted to deliver a range of therapeutic stimuli wirelessly, offering a versatile strategy for treating deep-seated pathologies.
- 2 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (40)
Open AccessIntratumoral therapeutic dust for chemo-photodynamic combination treatment
Implantable wireless ultrasound microdevices for intratumoral therapy are hindered by inadequate miniaturization for deep-seated sites and toxic lead-based piezoelectrics. Here, we report an injectable, lead-free, submillimeter therapeutic dust (TheraDust; 1.0 millimeters by 1.0 millimeters by 0.9 millimeters) for ultrasound-driven wireless chemo-photodynamic combined therapy. The core of the device is a lead-free tin-doped barium titanate piezoelectric ceramic that features a multiphase coexistence at physiological temperature and exhibits a high piezoelectric coefficient ( d 33 = 460 picocoulombs per newton). The TheraDust integrates with an ultrasound-responsive drug-loaded hydrogel for precise intratumoral injection. Under programmable ultrasound, it generates light for photodynamic therapy and triggers on-demand chemotherapeutic release for enhanced treatment. In animal models of breast cancer, the device achieved potent tumor suppression, reducing the final tumor volume to less than 3% after five treatment sessions (5 minutes each) and could be retrieved minimally invasively posttreatment. This platform can be adapted to deliver a range of therapeutic stimuli wirelessly, offering a versatile strategy for treating deep-seated pathologies.
- 12 September 2025
- Published by Elsevier in Journal of the European Ceramic Society
- Vol. 46 (2)
Achieving ultra-high Q×f values in Y2O3 ceramics by Sm substitution and enhancing electrical insulation
- 12 September 2025
- Published by Elsevier in Journal of the European Ceramic Society
- Vol. 46 (2)
Achieving ultra-high Q×f values in Y2O3 ceramics by Sm substitution and enhancing electrical insulation